Ana Matilla

Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib

Thomas Yau, Yoon‐Koo Kang, Tae‐You Kim et al. · JAMA Oncology · 2020 · 1.2K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

Influence of Hepatic Venous Pressure Gradient on the Prediction of Survival of Patients With Cirrhosis in the MELD Era *

Cristina Ripoll, Rafael Bañares, Diego Rincón et al. · Hepatology · 2005 · 246 citations · Full text

Medicine, Internal Medicine, Gastroenterology +16

Nivolumab (NIVO) + ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.

Thomas Yau, Yoon‐Koo Kang, Tae‐You Kim et al. · Journal of Clinical Oncology · 2019 · 230 citations

Medicine, Oncology, Pharmacology +15

CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis

Masatoshi Kudo, Ana Matilla, Armando Santoro et al. · Journal of Hepatology · 2021 · 226 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Efficacy and Safety of Sorafenib in Combination With Mammalian Target of Rapamycin Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation

Carlos Gómez-Martín, Javier Bustamante, J.F. Castroagudı́n et al. · Liver Transplantation · 2011 · 162 citations · Full text

Medicine, Oncology, Pharmacotherapy +17